What’s Going On With PENN Entertainment Stock Friday?

PENN Entertainment shares surge as shareholder Donerail Group pushes for strategic changes, citing undervaluation and poor performance.

PENN Entertainment, Inc. (NASDAQ:PENN)  shares are trading higher on Friday.

The company’s shareholder, Donerail Group, sent a letter to the company’s Board saying the company could get ‘up to double its current trading price in the event of a sale.’

Donerail Group, in a statement, said the company’s misguided interactive strategy and poor capital allocation have affected shareholder value. As a result, PENN Entertainment is currently trading at a steep discount to its intrinsic value, Donerail added.

The shareholder specifically raised concerns about the Board’s decision to reward CEO Jay Snowden with excessive compensation of nearly $100 million despite significant financial underperformance and stock price declines.

According to Benzinga Pro, PENN stock has lost over 32% in the past year.

Donerail Group also highlighted management’s track record of failed deals, including the headline-generating Barstool Sports sale for $1.

Earlier this month, the company reported worse-than-expected first-quarter financial results.

Total liquidity as of March 31, 2024 was $1.9 billion inclusive of $903.6 million in cash and equivalents. Traditional net debt as of the end of the quarter was $1.7 billion.

Price Action: PENN shares are trading higher by 17.1% to $17.13 at last check Friday.

Read Next: Donald Trump Floats Idea Of Bringing Back Adviser Peter Navarro For Potential Second Term Despite Prison Sentence: ‘I Would Absolutely Have Peter Back’

Photo via Shutterstock

Total
0
Shares
Related Posts
Read More

Supreme Court Signals Unlikelihood of Restricting Abortion Pill Access, Questions Legal Standing

The U.S. Supreme Court deliberates on abortion pill access amidst FDA regulations. Legal standing is scrutinized as justices weigh impacts on medical personnel and federal laws. This pivotal case follows significant changes in medication abortion protocols. Justices' decisions anticipated by June with potential implications for nationwide abortion rights

CVS